WEE1 promotes immune resistance in NANOG-high tumors by activating the HSP90A/TCL1/AKT pathway, decreasing the effectiveness of PD-1 blockade, and highlighting…
Read More
WEE1 promotes immune resistance in NANOG-high tumors by activating the HSP90A/TCL1/AKT pathway, decreasing the effectiveness of PD-1 blockade, and highlighting…
Read More